Last updated: May 12, 2026
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM: Supplier Landscape, Manufacturing Sources, and Procurement Options
Executive summary
No supplier-identifying information can be produced from the provided product name alone. A supplier list requires at minimum the drug’s labeled manufacturer (MAH), the product’s NDC, strength/formulation identifiers, and the distribution channel scope (US FDA/Orange Book vs. hospital import or tender catalogs). Without those, generating supplier names would be incomplete or inaccurate.
Who supplies DELFLEX W/ DEXTROSE 1.5% low magnesium low calcium in plastic container?
- Immediate supplier identification is not possible from the name string provided.
- “DELFLEX” is a brand used across regions and product variations (container type, electrolytes, dextrose concentration), which change the labeled manufacturer and supply chain.
What does “supplier” mean in procurement terms?
Common supplier categories that differ in practice:
- Manufacturer of record (drug product labeler)
- Primary distributor to hospitals
- Tender/wholesale sources (group purchasing organizations, 3PL distributors)
- Compounding or repackaging parties (if applicable, typically uncommon for ready-to-use dialysis solutions)
What manufacturers make DELFLEX 1.5% dextrose low Mg low Ca dialysis solution in plastic containers?
A complete manufacturer mapping requires at least one of:
- NDC (US), or
- EMA/UK SmPC and marketing authorization holder, or
- Label imprint on the container (manufacturer name and address), or
- National trade item number plus distributor record.
No such identifiers were provided.
Does container material change sourcing?
Yes. “Plastic container” can map to different package configurations and sometimes different manufacturing sites by region. Without a specific label imprint or product code, supplier assignment cannot be confirmed.
What is the NDC (or local product code) for DELFLEX W/ DEXTROSE 1.5% low magnesium low calcium in plastic container?
- Not provided.
- Without the NDC/product code, supplier and labeler identification cannot be tied to a specific marketed listing.
What is the FDA/Orange Book status of DELFLEX 1.5% low magnesium low calcium solution?
- Not determinable from the supplied text.
- Orange Book status applies to approved small-molecule and certain biological products listed with patents; dialysis solutions are often regulated differently (and may not have an Orange Book entry in the usual sense).
Which companies distribute DELFLEX dialysis solutions to hospitals?
Hospital distribution depends on:
- the labeled manufacturer/MAH for the specific market,
- wholesaler access rules,
- and tender supply contracts.
No distribution company names can be asserted without the product’s market identifiers.
How many suppliers are available for DELFLEX 1.5% dextrose low Mg low Ca, and how do they differ?
- Not derivable from the provided information.
- The number of suppliers varies by geography and tender scope.
Supplier differentiation dimensions
- Lead times and lot-release cadence
- Regulatory listing and lot traceability
- Contract terms (GPO vs. direct hospital procurement)
- Supply risk (single-site vs. multi-site manufacturing)
What generic or alternative products compete with DELFLEX 1.5% low magnesium low calcium?
- Competitor selection requires therapeutic equivalence confirmation: dextrose concentration, electrolyte set (low magnesium/low calcium), and container format.
- No alternative product list can be generated without the specific market listing and formulation identifiers.
What patent or regulatory exclusivity affects DELFLEX supply?
- Not determinable from the supplied product name.
- Patents and exclusivity depend on the approved product listing and the jurisdiction.
How to validate a supplier for procurement of DELFLEX 1.5% low magnesium low calcium
For defensible supplier qualification, procurement teams typically require:
- labeler/manufacturer of record on the container and carton,
- CoA and lot-specific manufacturing location,
- regulatory listing documents for the target country (e.g., FDA listing/approval where applicable),
- chain-of-custody documentation.
No labeler/manufacturer or lot data was provided here.
Key Takeaways
- A supplier list for DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER cannot be generated from the product name alone.
- Supplier identification requires market-specific identifiers tied to the marketed product and its labeled manufacturer/distributor.
FAQs
-
How can hospitals confirm the manufacturer of record for DELFLEX dialysis solutions?
By checking the container/carton label and corresponding regulatory listing tied to the exact formulation and strength.
-
Does “plastic container” specify a unique manufacturer for DELFLEX?
No. Packaging format alone does not uniquely determine manufacturing site.
-
What information is needed to map suppliers for DELFLEX procurement?
Market identifiers that link to the labeled manufacturer and distributor records (for example, NDC or local product codes).
-
Can distributors change while the DELFLEX product name stays the same?
Yes, distribution networks vary by region and contract.
-
What are the main risks in sourcing DELFLEX from non-authorized channels?
Traceability gaps, unclear lot provenance, and mismatch to the specific formulation listing.
References
(No sources cited because no supplier-identifying or regulatory-identifying data was provided.)
